Medical Affairs Lead BH
Pubblicato il 04-08-2026 - Altro in Italia
BU Brain Health
Neuraxpharm is looking for a Medical Affairs Lead for BU Brain Health based in Milan, Italy. We want individuals who will go the extra mile and make great things happen.
Your Mission
Provide exceptional clinical and scientific leadership for medical affairs activities and support strategies focused on the Brain Health Business Unit (BH), ensuring the scientific integrity of communication regarding pharmaceutical & nutraceutical products coming from the field force. The Medical Lead BH establishes, maintains, and develops relationships with opinion leaders and other relevant stakeholders, representing the third-level contact person for medical enquiries from doctors, pharmacists, and patients.
Your Major Accountabilities
Cover the role of Responsible for Scientific Information in AIFA (RSS).
Be responsible for scientific information on the field, providing timely and accurate training, and monitor communication delivered through promotional materials to ensure consistent, compliant, and ethical messaging in the medical domain.
Partner with the scientific community to exchange health outcome information and therapeutic benefits of the products.
Liaise with healthcare professionals to provide informed answers to medical questions surrounding the products.
Actively manage medical information with regard to the research, collection, and systematization of information materials useful to satisfy requests from all internal and external stakeholders (doctors, pharmacists, health professionals, patients).
Cooperate with all other activities addressed to the Medical Class, and provide assistance at Congresses, Symposia, or other medical-scientific events.
We Would Like You To Have
Bachelor's degree or higher education in medicines, pharmaceutical sciences, life sciences, or a related field.
2+ years of professional experience in a similar role in a pharma company in the CNS therapeutic area.
Experience in literature review, clinical trials, and clinical pharma